Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Design | 2 | 2024 | 186 | 1.500 |
Why?
|
| Hong Kong | 11 | 2025 | 29 | 1.120 |
Why?
|
| Biological Availability | 1 | 2024 | 116 | 0.850 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 62 | 0.840 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 1723 | 0.680 |
Why?
|
| Proteins | 1 | 2023 | 382 | 0.650 |
Why?
|
| Smoking Cessation | 3 | 2024 | 590 | 0.650 |
Why?
|
| Hot Temperature | 2 | 2024 | 141 | 0.620 |
Why?
|
| Awareness | 1 | 2019 | 73 | 0.580 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1019 | 0.560 |
Why?
|
| Neoplasms | 3 | 2022 | 1377 | 0.560 |
Why?
|
| Intention | 1 | 2019 | 108 | 0.550 |
Why?
|
| Smad4 Protein | 1 | 2017 | 8 | 0.520 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 41 | 0.510 |
Why?
|
| Curcumin | 1 | 2018 | 118 | 0.510 |
Why?
|
| Glucose | 1 | 2018 | 244 | 0.500 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 57 | 0.490 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 458 | 0.480 |
Why?
|
| Lactic Acid | 1 | 2016 | 112 | 0.480 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 216 | 0.460 |
Why?
|
| Glycolysis | 1 | 2015 | 71 | 0.440 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 68 | 0.440 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 159 | 0.410 |
Why?
|
| Humans | 22 | 2025 | 43102 | 0.400 |
Why?
|
| Inflammation | 1 | 2017 | 758 | 0.360 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 495 | 0.340 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 539 | 0.340 |
Why?
|
| Female | 13 | 2025 | 24698 | 0.340 |
Why?
|
| Phosphorylation | 3 | 2018 | 986 | 0.310 |
Why?
|
| Mental Health | 2 | 2024 | 385 | 0.300 |
Why?
|
| Breath Tests | 2 | 2024 | 24 | 0.260 |
Why?
|
| Male | 10 | 2025 | 23409 | 0.260 |
Why?
|
| Carbon Monoxide | 2 | 2024 | 47 | 0.250 |
Why?
|
| Middle Aged | 6 | 2025 | 12222 | 0.250 |
Why?
|
| Adult | 10 | 2025 | 13872 | 0.240 |
Why?
|
| Tobacco Industry | 1 | 2025 | 9 | 0.240 |
Why?
|
| Animals | 6 | 2024 | 16992 | 0.240 |
Why?
|
| Commerce | 2 | 2025 | 95 | 0.230 |
Why?
|
| Flavoring Agents | 1 | 2025 | 22 | 0.230 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 2676 | 0.230 |
Why?
|
| Ligands | 2 | 2023 | 388 | 0.220 |
Why?
|
| NF-kappa B | 2 | 2018 | 358 | 0.220 |
Why?
|
| Disease Progression | 2 | 2018 | 667 | 0.220 |
Why?
|
| Cotinine | 1 | 2024 | 44 | 0.210 |
Why?
|
| Pharmaceutical Preparations | 1 | 2024 | 94 | 0.200 |
Why?
|
| Saliva | 1 | 2024 | 119 | 0.200 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3156 | 0.200 |
Why?
|
| Young Adult | 6 | 2025 | 5080 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 112 | 0.190 |
Why?
|
| Nanotechnology | 1 | 2024 | 176 | 0.190 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 277 | 0.190 |
Why?
|
| Molecular Structure | 1 | 2023 | 570 | 0.170 |
Why?
|
| Fathers | 1 | 2021 | 38 | 0.170 |
Why?
|
| Tobacco Use Cessation | 1 | 2021 | 19 | 0.170 |
Why?
|
| Adolescent | 5 | 2025 | 6081 | 0.170 |
Why?
|
| Exosomes | 1 | 2022 | 126 | 0.160 |
Why?
|
| Behavior Therapy | 1 | 2021 | 180 | 0.160 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1455 | 0.160 |
Why?
|
| Interpersonal Relations | 1 | 2021 | 222 | 0.150 |
Why?
|
| Apoptosis | 2 | 2017 | 1568 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2017 | 2157 | 0.150 |
Why?
|
| Aerosols | 1 | 2019 | 54 | 0.150 |
Why?
|
| Acetylation | 1 | 2018 | 107 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2018 | 61 | 0.130 |
Why?
|
| Withanolides | 1 | 2017 | 10 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 34 | 0.130 |
Why?
|
| Hyperinsulinism | 1 | 2016 | 17 | 0.130 |
Why?
|
| Telomerase | 1 | 2017 | 42 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 347 | 0.130 |
Why?
|
| Social Class | 1 | 2019 | 291 | 0.130 |
Why?
|
| Ubiquitination | 1 | 2017 | 62 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 102 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2017 | 165 | 0.120 |
Why?
|
| Mice | 2 | 2018 | 6644 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2016 | 102 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 220 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 508 | 0.120 |
Why?
|
| Age Factors | 1 | 2019 | 1154 | 0.120 |
Why?
|
| Mice, Nude | 1 | 2017 | 408 | 0.120 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 237 | 0.120 |
Why?
|
| Deoxyglucose | 1 | 2015 | 18 | 0.110 |
Why?
|
| Health Status | 1 | 2019 | 442 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 532 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2015 | 37 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 52 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 384 | 0.110 |
Why?
|
| Models, Molecular | 1 | 2018 | 876 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2016 | 201 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 206 | 0.110 |
Why?
|
| China | 2 | 2025 | 229 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 183 | 0.100 |
Why?
|
| Phenotype | 1 | 2016 | 780 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 161 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2015 | 321 | 0.100 |
Why?
|
| Cell Movement | 1 | 2017 | 655 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1596 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1124 | 0.090 |
Why?
|
| Cell Survival | 1 | 2015 | 945 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 512 | 0.090 |
Why?
|
| Aged | 2 | 2024 | 8214 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1151 | 0.070 |
Why?
|
| Alcohol Drinking | 2 | 2024 | 609 | 0.060 |
Why?
|
| Exhalation | 1 | 2024 | 10 | 0.050 |
Why?
|
| Singapore | 1 | 2024 | 33 | 0.050 |
Why?
|
| Perception | 1 | 2025 | 215 | 0.050 |
Why?
|
| Linear Models | 1 | 2023 | 317 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2025 | 574 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 175 | 0.050 |
Why?
|
| Family Health | 1 | 2021 | 55 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2021 | 93 | 0.040 |
Why?
|
| Universities | 1 | 2024 | 559 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 420 | 0.040 |
Why?
|
| Smoking | 1 | 2025 | 1024 | 0.040 |
Why?
|
| Communication | 1 | 2020 | 210 | 0.040 |
Why?
|
| Models, Biological | 1 | 2022 | 712 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 989 | 0.030 |
Why?
|
| Students | 1 | 2024 | 626 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2017 | 60 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 74 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 127 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1600 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2022 | 518 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1772 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 883 | 0.030 |
Why?
|
| United States | 1 | 2024 | 5205 | 0.020 |
Why?
|